| Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility F Scaldaferri, V Gerardi, LR Lopetuso, F Del Zompo, F Mangiola, ... BioMed research international 2013, 2013 | 295 | 2013 |
| Gastrointestinal motility disorder assessment in systemic sclerosis E Savarino, F Mei, A Parodi, M Ghio, M Furnari, A Gentile, M Berdini, ... Rheumatology 52 (6), 1095-1100, 2013 | 110 | 2013 |
| The gut microbiota and immune system relationship in human graft-versus-host disease L Laterza, G Rizzatti, E Gaetani, P Chiusolo, A Gasbarrini Mediterranean journal of hematology and infectious diseases 8 (1), 2016 | 78 | 2016 |
| Binge drinking among adolescents is related to the development of alcohol use disorders: results from a cross-sectional study G Addolorato, GA Vassallo, G Antonelli, M Antonelli, C Tarli, A Mirijello, ... Scientific reports 8 (1), 12624, 2018 | 70 | 2018 |
| Role of yeasts in healthy and impaired gut microbiota: the gut mycome G Ianiro, G Bruno, L Lopetuso, F Bartoli Beghella, L Laterza, F D'Aversa, ... Current pharmaceutical design 20 (28), 4565-4569, 2014 | 68 | 2014 |
| Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: reorganisational response in a high-volume Italian … F Scaldaferri, D Pugliese, G Privitera, S Onali, LR Lopetuso, G Rizzatti, ... United European gastroenterology journal 8 (7), 775-781, 2020 | 48 | 2020 |
| Efficacy and mechanisms of action of fecal microbiota transplantation in ulcerative colitis: pitfalls and promises from a first meta-analysis F Scaldaferri, S Pecere, V Petito, D Zambrano, L Fiore, LR Lopetuso, ... Transplantation Proceedings 48 (2), 402-407, 2016 | 46 | 2016 |
| Gut microbiota during dietary restrictions: new insights in non-communicable diseases E Rinninella, M Cintoni, P Raoul, G Ianiro, L Laterza, LR Lopetuso, ... Microorganisms 8 (8), 1140, 2020 | 42 | 2020 |
| Multiparametric evaluation predicts different mid-term outcomes in Crohn’s disease L Laterza, AC Piscaglia, LM Minordi, I Scoleri, L Larosa, A Poscia, ... Digestive Diseases 36 (3), 184-193, 2018 | 40 | 2018 |
| Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication. F Scaldaferri, O Nardone, LR Lopetuso, V Petito, S Bibbò, L Laterza, ... European Review for Medical & Pharmacological Sciences 17, 2013 | 40 | 2013 |
| Irritable bowel syndrome and nickel allergy: what is the role of the low nickel diet? A Rizzi, E Nucera, L Laterza, E Gaetani, V Valenza, GM Corbo, ... Journal of Neurogastroenterology and Motility 23 (1), 101, 2017 | 38 | 2017 |
| Gut and reproductive tract microbiota adaptation during pregnancy: new insights for pregnancy-related complications and therapy M De Siena, L Laterza, MV Matteo, I Mignini, T Schepis, G Rizzatti, ... Microorganisms 9 (3), 473, 2021 | 37 | 2021 |
| Pancreatic function assessment. L Laterza, F Scaldaferri, G Bruno, A Agnes, I Boškoski, G Ianiro, V Gerardi, ... European Review for Medical & Pharmacological Sciences 17, 2013 | 37 | 2013 |
| 13C-octanoic acid breath test to study gastric emptying time. G Bruno, LR Lopetuso, G Ianiro, L Laterza, V Gerardi, V Petito, A Poscia, ... European Review for Medical & Pharmacological Sciences 17, 2013 | 35 | 2013 |
| Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under … F Scaldaferri, D D ‘Ambrosio, G Holleran, A Poscia, V Petito, L Lopetuso, ... PLoS One 12 (10), e0186575, 2017 | 31 | 2017 |
| Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study D Pugliese, G Privitera, F Crispino, N Mezzina, F Castiglione, G Fiorino, ... Alimentary pharmacology & therapeutics 56 (1), 95-109, 2022 | 27 | 2022 |
| Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome L Laterza, G Ianiro, I Scoleri, R Landi, G Bruno, F Scaldaferri, E Gaetani, ... Expert opinion on pharmacotherapy 16 (4), 607-615, 2015 | 27 | 2015 |
| Origin of celiac disease: How old are predisposing haplotypes? G Gasbarrini, O Rickards, C Martínez-Labarga, E Pacciani, F Chilleri, ... World journal of gastroenterology: WJG 18 (37), 5300, 2012 | 26 | 2012 |
| Tricks for interpreting and making a good report on hydrogen and 13C breath tests G D'Angelo, TA Di Rienzo, F Scaldaferri, F Del Zompo, M Pizzoferrato, ... European Review for Medical and Pharmacological Sciences, 2013 | 23 | 2013 |
| Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease AC Piscaglia, S Rutella, L Laterza, V Cesario, M Campanale, IA Cazzato, ... Journal of translational medicine 13, 1-9, 2015 | 19 | 2015 |
